Mikael Lantz (Former)

11 – 20 of 38

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/0673d984-25cd-4643-8f16-4be20e3f868d?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2019
Mark Prevalence of diabetes and presence of autoantibodies against zinc transporter 8 and glutamic decarboxylase at diagnosis and at follow up of Graves’ disease
Jonsdottir, Berglind ^LU ; Jönsson, Ida ^LU and Lantz, Mikael ^LU (2019) In Endocrine 64(1). p.48-54
- Contribution to journal › Article
Mark Alterations in levels of intermediate-chained acylcarnitines associate with weight-gain following reestablishment of euthyroidism in Graves’ disease
Al Majdoub, Mahmoud ^LU ; Lantz, Mikael ^LU and Spégel, Peter ^LU (2019) In Endocrine 63(1). p.164-166
- Contribution to journal › Article
Mark Simvastatin downregulates adipogenesis in 3T3-l1 preadipocytes and orbital fibroblasts from graves’ ophthalmopathy patients
Shahida, B. ^LU ; Johnson, P. Sahlstrand ^LU ; Jain, R. ^LU ; Brorson, H. ^LU ; Åsman, P. ^LU ; Lantz, M. ^LU and Planck, T. ^LU (2019) In Endocrine Connections 8(9). p.1230-1239
- Contribution to journal › Article
2018
Mark Study of Deiodinase Type 2 Polymorphisms in Graves' Disease and Ophthalmopathy in a Swedish Population
Shahida, Bushra ^LU ; Planck, Tereza ^LU ; Åsman, Peter ^LU and Lantz, Mikael ^LU (2018) In European Thyroid Journal 7(6). p.289-293
- Contribution to journal › Article
2017
Mark Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels
Al-Majdoub, Mahmoud ^LU ; Lantz, Mikael ^LU and Spégel, Peter ^LU (2017) In Thyroid : official journal of the American Thyroid Association 27(9). p.1109-1117
- Contribution to journal › Article
2016
Mark Adjuvant Treatment of Graves' Disease with Diclofenac : Safety, Effects on Ophthalmopathy and Antibody Concentrations
Lantz, Mikael ^LU ; Calissendorff, Jan ; Träisk, Frank ; Tallstedt, Leif ; Planck, Tereza ^LU ; Törring, Ove ; Hallengren, Bengt ^LU and Åsman, Peter ^LU (2016) In European Thyroid Journal 5(1). p.6-50
- Contribution to journal › Article
2015
Mark PROTEOMICS OF ORBITAL TISSUE IN THYROID-ASSOCIATED ORBITOPATHY.
Matheis, N ; Lantz, Mikael ^LU ; Grus, F H ; Ponto, K A ; Wolters, D ; Brorson, Håkan ^LU ; Planck, Tereza ^LU ; Shahida, Bushra ^LU ; Pitz, S and Pfeiffer, N , et al. (2015) In Journal of Clinical Endocrinology and Metabolism 100(12). p.1523-1530
- Contribution to journal › Article
Mark Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report.
Hallengren, Bengt ^LU ; Planck, Tereza ^LU ; Åsman, Peter ^LU and Lantz, Mikael ^LU (2015) In European Thyroid Journal 4(3). p.197-200
- Contribution to journal › Article
2014
Mark ASSOCIATION OF BTG2, CYR61, ZFP36, AND SCD GENE POLYMORPHISMS WITH GRAVES' DISEASE AND OPHTHALMOPATHY.
Planck, Tereza ^LU ; Shahida, Bushra ^LU ; Sjögren, Marketa ^LU ; Groop, Leif ^LU ; Hallengren, Bengt ^LU and Lantz, Mikael ^LU (2014) In Thyroid 24(7). p.1156-1161
- Contribution to journal › Article
Mark Increased TRAb and/or Low Anti-TPO Titers at Diagnosis of Graves' Disease are Associated with an Increased Risk of Developing Ophthalmopathy after Onset.
Lantz, Mikael ^LU ; Planck, Tereza ^LU ; Åsman, Peter ^LU and Hallengren, Bengt ^LU (2014) In Experimental and Clinical Endocrinology & Diabetes 122(2). p.113-117
- Contribution to journal › Article